Prevalence and type distribution of human papillomavirus infection in women from North Sardinia, Italy

BMC Public Health

Volumn 11, Issue , 2011, Pages

  Piana, Andrea ^a   Sotgiu, Giovanni ^a   Castiglia, Paolo ^a   Pischedda, Stefania ^a   Cocuzza, Clementina ^b   Capobianco, Giampiero ^a   Marras, Vincenzo ^a   Dessole, Salvatore ^a   Muresu, Elena ^a  

^a UNIVERSITY OF SASSARI   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; ARTICLE; FEMALE; GENETICS; GENOTYPE; HUMAN; ISOLATION AND PURIFICATION; ITALY; MIDDLE AGED; MIXED INFECTION; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; UTERINE CERVIX DISEASE; VAGINA SMEAR; VIROLOGY;

ADOLESCENT; ADULT; COINFECTION; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; ITALY; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; REAL-TIME POLYMERASE CHAIN REACTION; UTERINE CERVICAL DISEASES; VAGINAL SMEARS; YOUNG ADULT;

EID: 80053634476     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-11-785     Document Type: Article

References (26)

1. Papillomaviruses in the causation of human cancers-a brief historical account. zur Hausen H, Virology 2009 384 2 260 5 10.1016/j.virol.2008.11.046 19135222
2. Vaccination against human papilloma virus (HPV): epidemiological evidence of HPV in non-genital cancers. Mammas IN, Sourvinos G, Zaravinos A, Spandidos DA, Pathol Oncol Res 2011 17 1 103 19 10.1007/s12253-010-9288-0 20640607
3. The causal relation between human papillomavirus and cervical cancer. Bosch FX, Lorincz A, Mũoz N, Meijer CJ, Shah KV, J Clin Pathol 2002 55 4 244 65 10.1136/jcp.55.4.244 11919208 (Pubitemid 34293391)
4. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 100B (2011): A Review of Human Carcinogens: Biological Agents. http://monographs.iarc.fr/ENG/Monographs/vol100B/mono100B-11.pdf
5. Factors affecting transmission of mucosal human papillomavirus. Veldhuijzen NJ, Snijders PJ, Reiss P, Meijer CJ, van de Wijgert JH, Lancet Infect Dis 2010 10 12 862 74 Review 10.1016/S1473-3099(10)70190-0 21075056
6. Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers. Middleton K, Peh W, Southern S, Griffin H, Sotlar K, Nakahara T, El-Sherif A, Morris L, Seth R, Hibma M, Jenkins D, Lambert P, Coleman N, Doorbar J, J Virol 2003 77 19 10186 201 10.1128/JVI.77.19.10186-10201.2003 12970404 (Pubitemid 37129663)
7. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. de Sanjosé S, Diaz M, Castellsagué X, Clifford G, Bruni L, Mũoz N, Bosch FX, Lancet Infect Dis 2007 7 7 453 9 10.1016/S1473-3099(07)70158-5 17597569 (Pubitemid 46962343)
8. Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy. Agarossi A, Ferrazzi E, Parazzini F, Perno CF, Ghisoni L, J Med Virol 2009 81 3 529 35 10.1002/jmv.21347 19152401
9. Epidemiology and genotype distribution of human papillomavirus (HPV) in women of Sardinia (Italy). Masia G, Mazzoleni AP, Contu G, Laconi S, Minerba L, Montixi S, Montis F, Onano A, Porcedda E, Coppola RC, Vaccine 2009 27 Suppl 1 11 6 19480954
10. Typing of human papillomavirus in women with cervical lesions: prevalence and distribution of different genotypes. Sandri MT, Riggio D, Salvatici M, Passerini R, Zorzino L, Boveri S, Radice D, Spolti N, Sideri M, J Med Virol 2009 81 2 271 7 10.1002/jmv.21382 19107962
11. Prevalence and distribution of single and multiple HPV infections in cytologically abnormal cervical samples from Italian women. Gargiulo F, De Francesco MA, Schreiber C, Ciravolo G, Salinaro F, Valloncini B, Manca N, Virus Res 2007 125 2 176 82 10.1016/j.virusres.2006.12.017 17257705 (Pubitemid 46613818)
12. Correlation of high-risk human papillomavirus genotypes persistence and risk of residual or recurrent cervical disease after surgical treatment. Venturoli S, Ambretti S, Cricca M, Leo E, Costa S, Musiani M, Zerbini M, J Med Virol 2008 80 8 1434 40 10.1002/jmv.21198 18551620 (Pubitemid 351897416)
13. Lo screening cervicale nel 2009. Rapporto Nazionale PASSI 2009/Programmi di prevenzione individuale. http://www.epicentro.iss.it/passi/cervicale/Passi- cervice.pdf
14. Piano operativo del PRP Regione Sardegna 2010-2012. Regione Autonoma della Sardegna. http://www.ccm-network.it/documenti-Ccm/PNP-2010/programmazione/ Sardegna/screening-cervice.pdf
15. Gazzetta Ufficiale, Linee guida elaborate dalla Commissione Oncologica Nazionale in applicazione di quanto previsto dal Piano sanitario nazionale per il triennio 1994-1996, relativo all'azione programmata "Prevenzione e cura delle malattie oncologiche", concernenti l'organizzazione della prevenzione e dell'assistenza in oncologia n. 127 del 1/6/1996
16. National health plan 2006-2008. Italian Ministry of Health, http://www.ministerosalute.it/resources/static/primopiano/316/ PSN-2006-08-28-marzo.pdf
17. Plan for national prevention. http://www.ccm-network.it/en-National-Prev- Plan
18. Comparison of human papillomavirus genotyping using commercial assays based on PCR and reverse hybridization methods. Galan-Sanchez F, Rodriguez-Iglesias MA, APMIS 2009 117 10 708 15 10.1111/j.1600-0463.2009.02522.x 19775338
19. Prevalence and viral load of oncogenic human papillomavirus types associated with cervical carcinoma in a population of North Italy. Broccolo F, Chiari S, Piana A, Castiglia P, Dell'Anna T, Garcia-Parra R, Maneo A, Villa A, Leone EB, Perego P, Maida A, Mangioni C, Cocuzza CE, J Med Virol 2009 81 2 278 87 10.1002/jmv.21395 19107971
20. Automated extraction and quantitation of oncogenic HPV genotypes from cervical samples by a real-time PCR-based system. Broccolo F, Cocuzza CE, J Virol Methods 2008 148 1-2 48 57 Epub 2007 Nov 28 10.1016/j.jviromet.2007.10.003 18053585 (Pubitemid 351248983)
21. Performance Assessment of Eight High-Throughput PCR Assays for Viral Load Quantitation of Oncogenic HPV Types. Flores-Munguia R, Siegel E, Klimecki WT, Giuliano AR, J Mol Diagn 2004 6 2 115 124 10.1016/S1525-1578(10)60499-0 15096567 (Pubitemid 38578987)
22. Epidemiology of HPV infections and cervical cancer in Apulia: a survey study and current data analysis. Martinelli D, Chironna M, Tafuri S, Neve A, Caputi G, Prato R, Ann Ig 2007 19 6 499 508 18376570
23. Prevalence of human papilloma virus infection in women in Tourin, Italy. Ronco G, Ghisetti V, Segnan N, Snijders PJ, Gillio-Tos A, Meijer CJ, Merletti F, Franceschi S, Eur J Cancer 2005 41 297 305 10.1016/j.ejca.2004.07.005 15661556 (Pubitemid 40126963)
24. Vaccination against colonizing bacteria with multiple serotypes. Lipsitch M, Proc Natl Acad Sci USA 1997 94 6571 6576 10.1073/pnas.94.12.6571 9177259 (Pubitemid 27270726)
25. Public health paradoxes and the epidemiological impact of an HPV vaccine. Garnett GP, Waddell HC, J Clin Virol 2000 19 1-2 101 11 10.1016/S1386-6532(00) 00129-3 11091153
26. Differences in incidence and co-occurrence of vaccine and nonvaccine human papillomavirus types in Finnish population before human papillomavirus mass vaccination suggest competitive advantage for HPV33. Merikukka M, Kaasila M, Namujju PB, Palmroth J, Kirnbauer R, Paavonen J, Surcel HM, Lehtinen M, Int J Cancer 2011 128 5 1114 9 10.1002/ijc.25675 20839258